TLI Eyes on the Future

Home
United States
McLean, VA
TLI Eyes on the Future

Contact information, map and directions, contact form, opening hours, services, ratings, photos, videos and announcements from TLI Eyes on the Future, Nonprofit Organization, 1750 Tysons Boulevard Suite 1500, McLean, VA.

TLI is excited to develop a portal designed to reach the millions of people who are affected by macular degeneration and build a resource and information platform which will serve as a trusted source of information.

05/28/2025

👁️ Protect Your Sight – Know the Signs of AMD! 🧓

Age-Related Macular Degeneration (AMD) is a leading cause of vision loss in adults over 50. It can sneak up without pain or early symptoms — but early detection can save your sight! 🕵️‍♀️

🔍 Watch for:

• Blurry or distorted central vision
• Difficulty reading or recognizing faces
• Dark or empty spots in your vision

🧠 Your eyes are windows to your brain and your independence. Let’s raise awareness and encourage regular eye exams! 💬 📅 May is a great time to schedule your check-up and share this message with loved ones.

Together, we can fight vision loss. 💪

👓🧬💙

05/27/2025

This Memorial Day, We Remember.

At TLI Eyes on the Future, we are deeply grateful for the courage, dedication, and selflessness of our fallen heroes.

Today, we reflect on their legacy and the values they fought to protect.

Let us never forget their service. 🕊️

🌟

05/23/2025

👁️✨ Your Vision Matters – Let’s Talk About AMD! 🧓👵

Age-Related Macular Degeneration (AMD) is one of the leading causes of vision loss in people over 50. It affects your central vision, making everyday tasks like reading, driving, or recognizing faces harder. 😢

But here’s the good news: 🩺 Early detection and lifestyle changes can help slow its progression!

🥦 Eat leafy greens
🕶️ Protect your eyes from UV light
🚭 Avoid smoking
👁️ Get regular eye exams

Let’s spread awareness and protect the gift of sight! 💙

👓🧬🌟

05/14/2025

👁️ Did you know? Nearly 20 million Americans aged 40+ are living with some form of Age-Related Macular Degeneration (AMD) — and by age 75, 1 in 3 will be affected. 😮

🧠 AMD doesn’t just impact vision — it affects independence, mental health, and quality of life. But there’s hope. Early detection and timely treatment can make all the difference. ⏱️

💡 Let’s shine a light on:
🔹 Early detection & risk reduction
🔹 The impact of vision loss on daily life
🔹The connection between AMD and brain health
🔹 Advocacy for better access to care

📅 Don’t wait if you notice sudden vision changes like blurriness or wavy lines. Time is vision. 🕒 📣 Share this to spread awareness and help protect the sight of millions. 💙

04/28/2025

Clinicians and researchers can analyze the functional changes in the macula by evaluating neural markers. However, there are limited methods available to elicit these neural markers.

Recent information published in Frontiers discusses a study that proposes using modified videos with embedded frequency tags to elicit the neural markers. Early results from this study appear to be promising.

Read more:
https://www.frontiersin.org/journals/human-neuroscience/articles/10.3389/fnhum.2025.1569282/abstract

The Thought Leadership & Innovation Foundation (TLI) is building "Eyes on the Future," a first-of-its-kind patient portal for Age-Related Macular Degeneration (AMD) patients. Currently, there's no dedicated resource for AMD patients to seek information on their disease.

At TLI, we believe AMD patients should have access to vital information and increased knowledge for better understanding and managing their own care. There are many benefits to this patient portal.

Explore the site here: https://lnkd.in/gFfvKTmM

🌟 👁️ 🎉 💡 🤝 👁️ 👴 👩‍⚕️ 🏥 🤝 💡 📱 🖥️ 🌟 🚀 ⚙️ 💉

04/21/2025

Scientists at Brown University have conducted a study on mice to investigate the use of gold nanoparticles combined with near-infrared light to restore vision in cases of retinal disorders. This study is in its early stages and not ready for use in a clinical setting, but it shows promising results and could offer patients with macular degeneration and other retinal disorder a less invasive treatment method.

Read more:
https://neurosciencenews.com/gold-nanoparticles-vision-amd-28659/

The Thought Leadership & Innovation Foundation (TLI) is building "Eyes on the Future," a first-of-its-kind patient portal for Age-Related Macular Degeneration (AMD) patients. Currently, there's no dedicated resource for AMD patients to seek information on their disease.

At TLI, we believe AMD patients should have access to vital information and increased knowledge for better understanding and managing their own care. There are many benefits to this patient portal.

Explore the site here: https://lnkd.in/gFfvKTmM

🌟 👁️ 🎉 💡 🤝 👁️ 👴 👩‍⚕️ 🏥 🤝 💡 📱 🖥️ 🌟 🚀 ⚙️ 💉

04/17/2025

The Ophthalmologist published an article written by Shawn Murphy, Vice President of Thought Leadership and Innovation Foundation regarding Age-Related Macular Degeneration.

By 2040, it is estimated that 288 million people globally will be affected by some form of AMD. Early diagnosis is key to preserving vision for as long as possible. The AMD portal will be a vital resource for AMD patients and caregivers, providing resources for support and treatment as well as collecting real-world data about the success of AMD treatments, patient demographics and more.

Read more:
https://theophthalmologist.com/issues/2025/articles/apr/amd-action-required/

The Thought Leadership & Innovation Foundation (TLI) is building "Eyes on the Future," a first-of-its-kind patient portal for Age-Related Macular Degeneration (AMD) patients. Currently, there's no dedicated resource for AMD patients to seek information on their disease.

At TLI, we believe AMD patients should have access to vital information and increased knowledge for better understanding and managing their own care. There are many benefits to this patient portal.

Explore the site here: https://lnkd.in/gFfvKTmM

🌟 👁️ 🎉 💡 🤝 👁️ 👴 👩‍⚕️ 🏥 🤝 💡 📱 🖥️ 🌟 🚀 ⚙️ 💉

04/10/2025

A new study conducted by researchers at Case Western Reserve University and Cleveland Clinic Cole Eye Institute in collaboration with U.S. Department of Veterans Affairs worked to identify risk factors for AMD.

This study is unique in that it included more than 287,000 veterans enrolled in the Million Veteran Program and several other independent biobanks to create the largest study of AMD genetic risk factors. It is also the first study that included people of diverse ancestry. This gives a better picture of who is at risk for AMD, confirming previous beliefs and even revealed new genes linked to AMD.

Read more:
https://thedaily.case.edu/researchers-at-case-western-reserve-university-cleveland-clinic-cole-eye-institute-collaborate-with-u-s-department-of-veterans-affairs-to-identify-genetic-risks-for-age-related-macular-degeneration/

The Thought Leadership & Innovation Foundation (TLI) is building "Eyes on the Future," a first-of-its-kind patient portal for Age-Related Macular Degeneration (AMD) patients. Currently, there's no dedicated resource for AMD patients to seek information on their disease.

At TLI, we believe AMD patients should have access to vital information and increased knowledge for better understanding and managing their own care. There are many benefits to this patient portal.

Explore the site here: https://lnkd.in/gFfvKTmM

# 🌟 👁️ 🎉 💡 🤝 👁️ 👴 👩‍⚕️ 🏥 🤝 💡 📱 🖥️ 🌟 🚀 ⚙️ 💉

01/23/2025

Verywell Health has released a recent article that discussed breakthroughs in AMD treatments that may help slow disease progression and avoid vision loss.

Read more:
https://www.verywellhealth.com/macular-degeneration-emerging-treatments-5071096

The Thought Leadership & Innovation Foundation (TLI) is building "Eyes on the Future," a first-of-its-kind patient portal for Age-Related Macular Degeneration (AMD) patients. Currently, there's no dedicated resource for AMD patients to seek information on their disease.

At TLI, we believe AMD patients should have access to vital information and increased knowledge for better understanding and managing their own care. There are many benefits to this patient portal.

Explore the site here: https://lnkd.in/gFfvKTmM

🌟 👁️ 🎉 💡 🤝 👁️ 👴 👩‍⚕️ 🏥 🤝 💡 📱 🖥️ 🌟 🚀 ⚙️ 💉

12/18/2024

Do you have blurry vision or loss of central vision? Do you have trouble driving, reading or recognizing faces? You might be suffering from age-related macular degeneration. This condition is a progressive disease that currently affects approximately 11 million people and affects the retina, a structure in the back of the eye. High blood pressure, heart disease, diabetes, even genetics, are a few of the known factors that can lead to AMD.

Read more:
https://www.yahoo.com/news/age-related-macular-degeneration-rob-091003859.html

The Thought Leadership & Innovation Foundation (TLI) is building "Eyes on the Future," a first-of-its-kind patient portal for Age-Related Macular Degeneration (AMD) patients. Currently, there's no dedicated resource for AMD patients to seek information on their disease.

At TLI, we believe AMD patients should have access to vital information and increased knowledge for better understanding and managing their own care. There are many benefits to this patient portal.

Explore the site here: https://lnkd.in/gFfvKTmM

🌟 👁️ 🎉 💡 🤝 👁️ 👴 👩‍⚕️ 🏥 🤝 💡 📱 🖥️ 🌟 🚀 ⚙️ 💉

12/13/2024

Did you know there are two types of Age-Related Macular Degeneration? Dry AMD is the early form of the disease and is treatable and curable. Dry AMD accounts for 85-90% of all cases. Wet AMT is found in about 10% of cases, but accounts for 90% of Macular Degeneration

The Thought Leadership & Innovation Foundation (TLI) is building "Eyes on the Future," a first-of-its-kind patient portal for Age-Related Macular Degeneration (AMD) patients. Currently, there's no dedicated resource for AMD patients to seek information on their disease.

At TLI, we believe AMD patients should have access to vital information and increased knowledge for better understanding and managing their own care. There are many benefits to this patient portal.

Explore the site here: https://lnkd.in/gFfvKTmM

🌟 👁️ 🎉 💡 🤝 👁️ 👴 👩‍⚕️ 🏥 🤝 💡 📱 🖥️ 🌟 🚀 ⚙️ 💉

11/18/2024

The Calibr-Skaggs Institute for Innovate Medicines is working on small molecule drugs that, if successful, will restore function to people with early-stage AMD.

Read more below

https://www.ophthalmologytimes.com/view/researchers-focusing-on-regenerative-treatments-for-amd-and-other-age-related-conditions

The Thought Leadership & Innovation Foundation (TLI) is building "Eyes on the Future," a first-of-its-kind patient portal for Age-Related Macular Degeneration (AMD) patients. Currently, there's no dedicated resource for AMD patients to seek information on their disease.

At TLI, we believe AMD patients should have access to vital information and increased knowledge for better understanding and managing their own care. There are many benefits to this patient portal.

Explore the site here: https://lnkd.in/gFfvKTmM

Ophthalmology Times

-SkaggsInstituteForInnovativeMedicines 🌟 👁️ 🎉 💡 🤝 👁️ 👴 👩‍⚕️ 🏥 🤝 💡 📱 🖥️ 🌟 🚀 ⚙️ 💉

Address

1750 Tysons Boulevard Suite 1500
McLean, VA
22102

Website

https://givebutter.com/eyes-on-the-future

Alerts

Be the first to know and let us send you an email when TLI Eyes on the Future posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Want your organization to be the top-listed Non Profit Organization in McLean?